Annovis Bio
ANVS • NYSE
Annovis Bio is a biotechnology company in the healthcare sector trading on NYSE, led by CEO Maria L. Maccecchini, with a market cap of $57.6M.
CEOMaria L. Maccecchini
Next Earnings
Upcoming earnings announcement for Annovis Bio
Date
Tuesday, May 12, 2026 (in a month)
Timing
Time TBD (2:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.36
Earnings History
Past 12 earnings reports for Annovis Bio
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | Q4 2025 | -$0.39Est: -$0.34 | -14.7% | - | — |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.37Est: -$0.37 | 0.0% | - | — | 10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.32Est: -$0.38 | +15.8% | - | — | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.32Est: -$0.29 | -10.3% | — | — | 10-Q |
| Mar 21, 2025 | Q4 2024 | -$0.43Est: -$0.20 | -115.0% | - | — | 10-K |
| Nov 8, 2024 | Q3 2024 | -$0.97Est: -$0.38 | -155.3% | - | — | 10-Q |
| Aug 15, 2024 | Q2 2024 | -$0.44Est: -$0.50 | +12.0% | - | — | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.72Est: -$0.80 | +10.0% | - | — | 10-Q |
| Apr 1, 2024 | Q4 2023 | -$2.33Est: -$1.30 | -79.2% | - | — | 10-K |
| Nov 8, 2023 | Q3 2023 | -$1.63Est: -$1.09 | -49.5% | - | — | — |
| Aug 15, 2023 | Q2 2023 | -$1.07Est: -$1.14 | +6.1% | - | — | 10-Q |
| May 11, 2023 | Q1 2023 | -$1.19Est: -$0.33 | -260.6% | - | — | — |